Rubin Lab

RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

SARS Vaccine and IBD Tweetorial Summary from December 1

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Three waves of Illness from the COVID-19 Pandemic

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

VIDEO: Social media has been a ‘life saver’ during COVID-19 pandemic

Watch this video exclusive, to hear David T. Rubin, MD highlight how the COVID-19 pandemic changed the use of social media.

Approach to Management and Interpretation of Testing Results in Patients with IBD, with Particular Attention to Restarting Therapy

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine As testing for SARS-CoV-2 is expanded and serologic antibody testing becomes available, we are faced with a number of different clinical scenarios. I have outlined the different situations...

How should we support the healthcare worker with IBD who is receiving immune therapies during the SARS-CoV-2 pandemic?

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine (Posted to IBD-circle.within3.com on March 21, 2020) Dear Colleagues, I have been fielding lots of questions about whether our IBD patients on immune therapies should stay home from work....

How should you treat active IBD during the SARS-CoV-2 pandemic?

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine (Posted to IBD-circle.within3.com on March 21, 2020) Colleagues, A question that has come up recently is how we should approach treating active IBD during the SARS-CoV-2 pandemic. Here are my...

Dr. Rubin Disscusses Probiotics, Prebiotics, and Why Your Gut is a Window to Your Overall Health

"Your intestines are the center of the universe." Listen to Dr. Rubin's appearance on WGN Nightside radio discussing the gut microbiome, IBD and other human diseases. You can find the full recording here.

Dr. David Rubin receives the Bruce and Cynthia Sherman Charitable Foundation’s 2020 Sherman Prize

Dr. Rubin was recently announced as one of three recipients of the 2020 Sherman Prize. Sherman Prize recipients "are outstanding individuals who consider the whole patient experience — not just the serious symptoms, but also the psychological and practical components...

Dr. Rubin Taps in on “IBD Community Throwing Elbows Over Value of TDM” in Gastroenterology and Endoscopy News

Dr. Mark Silverberg, Dr. David T Rubin, Dr. Laura Targownik, and Dr. Charabaty excitingly discuss why IBD specialists are divided on the topic of therapeutic drug monitoring (TDM). “If the drug is going to work but isn’t present in the body, it doesn’t do its job,”...

What Can We Do To Prevent COVID-19?

Click here for the full video discussing the use of COVID-19 vaccines to prevent COVID-19 infections in patients with inflammatory bowel disease.

Lee Matricaria’s Story

How IBD Can Affect Patients’ Career and School Choices

IBD, perhaps more than other chronic illnesses, can have a definite impact on a patient’s career choices and school performance. Therefore, I have definitely seen patients make decisions that are affected by their IBD. However, more often, I’ve seen patients overcome...